New validated assessment tools allow clinicians to better assess the level of real-life functioning in patients with schizophrenia.
New formulation associated with delayed time to impending relapse, as well as improvements on measures of symptom severity and treatment response.
Mental health advocate calls for a multidisciplinary approach to treating patients with severe mental illness.
Study indicates that nonspecific physical symptoms such as pain, weakness, and shortness of breath may indicate PTSD or depression.
Study reveals that psychiatric comorbidities are common in patients with terminal cancer and illustrates the important role psychiatrists can play in palliative and end-of-life care.
Clinicians who treat patients with atypical antipsychotics should be aware of the weight gain potential associated with each medication in this class, and select the most appropriate medication to ensure patient compliance and prevent relapse.
A poster presented at the American Psychiatric Association 64th Institute on Psychiatric Services examined whether depot medications work better than oral agents in schizophrenia.
Mental health expert says that the key to improving care is to integrate medical care into mental health settings, and introduce mental health care competence into primary care.
Posters present results of clinical trials that examined lurasidone as monotherapy and as part of combination therapy in patients with bipolar 1 depression with or without rapid cycling and without psychotic features.
